Gregory D Davis Sangamo Therapeutics, Inc (SGMO) insider trading activity

Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 193,791 shares of SGMO, which is worth approximately $85,268. The most recent transaction as insider was on Nov 24, 2025, when has been sold 723 shares (Common Stock) at a price of $0.42 per share, resulting in proceeds of $303. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 194K

3.69% 3M change

4.0% 12M change

Total Value Held $85,268

Gregory D Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2025	SELL Payment of exercise price or tax liability	$303 $0.42 p/Share	723 Reduced 0.37%	193,791 Common Stock
Oct 22 2025	SELL Payment of exercise price or tax liability	$4,427 $0.66 p/Share	6,708 Reduced 3.33%	194,514 Common Stock
Aug 24 2025	SELL Payment of exercise price or tax liability	$426 $0.59 p/Share	723 Reduced 0.36%	201,222 Common Stock
Jul 22 2025	SELL Payment of exercise price or tax liability	$3,219 $0.48 p/Share	6,708 Reduced 3.21%	201,945 Common Stock
May 24 2025	SELL Payment of exercise price or tax liability	$339 $0.47 p/Share	723 Reduced 0.35%	208,653 Common Stock
Apr 22 2025	SELL Payment of exercise price or tax liability	$5,232 $0.78 p/Share	6,708 Reduced 3.1%	209,376 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$486 $0.96 p/Share	507 Reduced 0.3%	166,358 Common Stock

Feb 25 2025	BUY Grant, award, or other acquisition	-	49,726 Added 18.71%	216,084 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$705 $1.0 p/Share	705 Reduced 0.42%	166,865 Common Stock
Jan 22 2025	SELL Payment of exercise price or tax liability	$35,024 $1.15 p/Share	30,456 Reduced 15.38%	167,570 Common Stock
Nov 25 2024	SELL Payment of exercise price or tax liability	$979 $1.94 p/Share	505 Reduced 0.25%	201,863 Common Stock
Nov 24 2024	SELL Payment of exercise price or tax liability	$1,355 $1.88 p/Share	721 Reduced 0.36%	202,368 Common Stock

GDD

Gregory D Davis

Head of Research & Technology

Richmond, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Value

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO

Account